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Target-Derived GFR1 as an Attractive Guidance
Signal for Developing Sensory and Sympathetic
Axons via Activation of Cdk5
rons (Lin et al., 1993). GDNF was subsequently found
to have similar effects in motorneurons (Henderson et
al., 1994; Li et al., 1995; Oppenheim et al., 1995), other
neuronal populations in the central nervous system (Are-
nas et al., 1995; Ha et al., 1996; Mount et al., 1995) and
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in the peripheral nervous system, where it promotes the17177 Stockholm
survival of embryonic sympathetic, parasympathetic,Sweden
and sensory neurons (Buj-Bello et al., 1995; Trupp et
al., 1995). The physiological relevance of the in vitro
effects of GDNF on the survival of peripheral neuronsSummary
has been substantiated by the reduction in the number
of sensory, sympathetic, and enteric neurons observedImmobilized and diffusible molecular cues regulate
in GDNF mutant mice (Moore et al., 1996; Pichel et al.,axon guidance during development. GFR1, a GPI-
1996; Sa´nchez et al., 1996).anchored receptor for GDNF, is expressed as both
Three close mammalian homologs of GDNF have beenmembrane bound and secreted forms by accessory
identified, Neurturin (NTN), Persephin (PSP), and Ar-nerve cells and peripheral targets of developing sen-
temin (ART) (Airaksinen and Saarma, 2002). An unusualsory and sympathetic neurons during the period of
feature of the receptor complex for GDNF family ligandstarget innervation. A relative deficit of GFR1 in devel-
is the requirement of two receptor subunits, one special-oping axons allows exogenous GFR1 to capture
ized in transmembrane signaling, the c-Ret receptor ty-GDNF and present it for recognition by axonal c-Ret
rosine kinase (Durbec et al., 1996; Trupp et al., 1996),receptors. Exogenous GFR1 potentiates neurite out-
and another involved in ligand binding, the glycosyl-growth and acts as a long-range directional cue by
phosphatidyl inositol (GPI)-anchored co-receptor namedcreating positional information for c-Ret-expressing
GDNF family receptor (GFR) (Jing et al., 1996; Treanoraxons in the presence of a uniform concentration of
et al., 1996). c-Ret is unable to bind GDNF family ligandsGDNF. Soluble GFR1 prolongs GDNF-mediated acti-
on its own but can be activated in a complex with GFRs.vation of cyclin-dependent kinase 5 (Cdk5), an event
Different members of the GDNF ligand family utilize dif-required for GFR1-induced neurite outgrowth and
ferent GFR co-receptors, although there is some over-axon guidance. Together with GDNF, target-derived
lap in specificity among the four known GFRs. GDNFGFR1 can function in a non-cell-autonomous fashion
signals primarily via the GFR1 receptor (Klein et al.,as a chemoattractant cue with outgrowth promoting
1997; Sanicola et al., 1997), although it is to some extentactivity for peripheral neurons.
also able to use GFR2 (Airaksinen and Saarma, 2002).
Lack of GFR1 results in a 15% loss of sensory neuronsIntroduction
in the nodose ganglion (Cacalano et al., 1998). The fact
that 40% of these cells are missing in GDNF mutant miceTarget-derived factors play a prominent role during the
indicates that GDNF may be utilizing other receptors indevelopment and maintenance of the nervous system.
these cells, presumably GFR2, in addition to GFR1.The first step in establishing specific neuronal connec-
On the other hand, there appears not to be any cell losstions requires axons to navigate with precision to their
in the superior cervical ganglion of GFR1 mutant micetargets. This process is controlled in part by external
(Cacalano et al., 1998), and one group reported the de-
cues which define pathways to the target area. Such
tection of tyrosine hydroxylase (TH)-positive fibers asso-
cues include extracellular matrix components, mole-
ciated with facial blood vessels (Enomoto et al., 1998),
cules present in the membrane of neighboring cells, suggesting that at least some sympathetic fibers were
and soluble factors. Several families of attractive and able to reach this target. The paravertebral sympathetic
repulsive guidance molecules are involved in the tar- chain has not yet been analyzed in GFR1 knockout
geted growth of axons, including extracellular matrix mice.
proteins, netrins, slits, semaphorins, ephrins, and neuro- Although both c-Ret and GFRs are required for re-
trophic factors such as hepatocyte growth factor (HGF), sponsiveness to GDNF family ligands, GFR receptors
members of the transforming growth factor  (TGF-) are widely expressed in the absence of c-Ret (Yu et al.,
superfamily, and neurotrophins. Neurotrophic factors 1998), suggesting alternative roles for “ectopic” sites of
are best known for their role in regulating neuronal sur- GFR expression. We have recently proposed that
vival. However, work during the last years has estab- GFRmolecules may function in a non-cell-autonomous
lished that these molecules can also act in a paracrine fashion to capture GDNF and present it to c-Ret recep-
way to regulate the direction of axonal growth. tors in trans. In particular, we found that exogenous
GDNF (glial cell line-derived neurotrophic factor) is GFR1 supplied together with GDNF potentiates intra-
a distant member of the transforming growth factor  cellular signaling and neuronal survival of developing
superfamily, originally discovered by its ability to pro- sensory neurons (Paratcha et al., 2001). A common fea-
mote the survival of ventral midbrain dopaminergic neu- ture of GPI-anchored molecules is that they are found
as both membrane bound and soluble forms. We have
also established that GFR1 can be released from the1Correspondence: carlos.ibanez@neuro.ki.se
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surface of neuronal and Schwann cells and from ex- of GFR1 was confirmed by whole-mount immunofluo-
rescence of explanted E9 nodose ganglia, which showedplants of sciatic nerve. Interestingly, release of GFR1
was greatly enhanced in sciatic nerve explants taken prominent GFR1 expression in the ganglion proper
(Figures 1Da–1Dc) and cells within it (Figures 1Dd–1Df),one week after a crush lesion, suggesting a physiologi-
cal role for the released receptors in the injury response but little or no immunoreactivity in fibers exiting from
the ganglion (Figures 1Dg–1Di). These observations sug-(Paratcha et al., 2001). It is known that nerve regrowth
and regeneration mimics many of the same cellular gest a relative deficit of GFR1 molecules in developing
axons and growth cones of sensory and sympatheticevents and shares many of the same molecular mecha-
nisms that regulate axonal growth and target innervation neurons compared to c-Ret. Thus, the expression of
GDNF receptors in peripheral targets, and their subcellu-during development. It became, therefore, of interest to
study possible roles of target-derived GFR molecules lar localization in developing neurons, are consistent
with a role for GFR1 as a target-derived factor.in axonal growth during development.
In the work presented here, we have investigated
whether the expression and release of GFR1 molecules Release of Functional GFR1 Molecules
by peripheral target tissues during the period of innerva- by Targets of Sensory Neurons
tion could represent a target-derived cue for ingrowing A prerequisite for the action of GFR1 as a soluble medi-
axons. To approach this question, we have examined ator of GDNF responses in vivo is its release from the
the relationship between expression of GDNF receptors membrane of GFR1-expressing cells. In order to deter-
in peripheral target tissues and axonal growth and che- mine whether bioactive GFR1 was synthesized and
moattractant activities of GFR1 on sensory and sympa- secreted by targets tissues, we analyzed the release of
thetic axons during embryonic development. We have this molecule ex vivo in conditioned medium of ex-
also investigated the signaling mechanisms underlying planted heart and carotid body isolated from E9 chicken
the activities of exogenous GFR1 in axon growth and embryos. GFR1 could be detected by Western blotting
guidance. in the supernatants of both tissues (Figure 1E). GFR1
was not detected in conditioned medium of fibroblasts
that do not express this receptor (Figure 1E). In theResults
presence of GDNF, conditioned media of heart and ca-
rotid body were able to stimulate c-Ret activation inDevelopmental Expression of GFR1 in Nodose
trans in fibroblast cells expressing this receptor (FigureGanglion and Its Targets
1F), indicating the presence of biologically active solubleTo determine whether soluble GFRs could represent
GFR1. Conditioned medium did not stimulate c-Rettarget-derived diffusible molecules involved in axon
phosphorylation in the absence of GDNF (Figure 1F).guidance, we examined the developmental pattern of
mRNA expression of GDNF receptors in nodose gan-
glion and in two of its peripheral targets, heart and Soluble GFR1 Potentiates Neurite Outgrowth
during Early Development of Sensorycarotid body, in chicken embryos. RT-PCR analysis re-
vealed that both c-Ret and GFR1 mRNAs are ex- and Sympathetic Ganglia
We next investigated whether soluble GFR1 presentedpressed in the nodose ganglion between embryonic day
6 (E6) and E16 without significant variation in their levels in trans together with GDNF could influence neurite out-
growth in E9 nodose and paravertebral sympatheticof expression (Figure 1A). No expression of c-Ret mRNA
was observed in carotid body and heart at any of the ganglia. As expected, a saturating dose of GDNF (100
ng/ml) induced the extension of neurites from both no-embryonic stages studied (Figure 1A). On the other
hand, GFR1 mRNA expression was readily detected in dose and sympathetic ganglion explants (Figure 2A, see
also Supplemental Figure S1 at http://www.neuron.org/both targets, with higher levels during earlier stages (E6
to E13) and lower levels at E16. A quantitative analysis cgi/content/full/36/3/387/DC1). Addition of a soluble
GFR1-Fc fusion protein promoted a robust and dose-using real-time PCR revealed a progressive reduction
of GFR1 mRNA expression in the two tissues between dependent increase in this response, exceeding that
obtained with a saturating dose of GDNF (Figure 2A). InE6 and E16 (Figure 1B). GDNF itself was predominantly
expressed by target cells (data not shown), in agreement the absence of GDNF, exogenous GFR1-Fc had no
effect on neurite outgrowth (Figure 2A). The responsewith previous results (Buj-Bello et al., 1995; Erickson et
al., 2001; Nosrat et al., 1996). of nodose and sympathetic ganglia at different stages of
development was evaluated by measuring both neuriteWe next determined the spatial localization of GDNF
receptors in dissociated cultures of E9 nodose and para- length and area of growth outside the explant. The ef-
fects of soluble GFR1-Fc on both these parametersvertebral sympathetic ganglion neurons by immunofluo-
rescence. This analysis demonstrated that the majority were more pronounced at earlier times of development
(E6 and E9), coinciding with a very low or negligibleof the neurons express GFR1 and c-Ret. Intriguingly,
GFR1 was mainly localized to the cell body, with minor spontaneous growth in control explants (Figure 2B). In
the nodose ganglion, the effect of soluble GFR1-Fc atimmunoreactivity along the neurites and in growth cones
(Figure 1C and data not shown). In several cases, sen- E13 was modest but significant on both the area and
the length of neurite outgrowth (Figure 2B). GDNF alonesory neurons displayed a segmented pattern of GFR1
immunoreactivity along the neurites (Figure 1C). In had no effect at this age. On the other hand, sympathetic
ganglion explants still showed a robust response toagreement with previous results (Worley et al., 2000),
c-Ret was detected in cell bodies, along the neurites GFR1-Fc at E13 (Figure 2B). Neither nodose nor sym-
pathetic ganglion explants responded to treatment withand in growth cones (data not shown). The localization
GFR1 and Cdk5 in Axon Growth and Guidance
389
Figure 1. Developmental Expression and Release of GFR1 in Nodose Ganglion and Its Targets
(A) Expression of GDNF receptors in chicken nodose ganglion and peripheral targets during embryonic development examined by RT-PCR.
Control samples without reverse transcriptase (RT) are also shown. Expression of the house-keeping gene L27 was used as loading control.
NG E9, embryonic day 9 nodose ganglion.
(B) Quantitative analysis of developmental expression of GFR1 mRNA by real-time PCR in chicken heart and carotid body between E6 and
E16. Shown are averages  SD of triplicate determinations.
(C) Photomicrographs of dissociated cultures of E9 chick nodose ganglion neurons visualized by DIC optics (left) and by immunofluorescence
after staining with anti-GFR1 antibodies (right). Arrowheads indicate cell bodies. Small arrows denote discontinuous regions of GFR1
staining along sensory axons.
(D) Whole-mount immunohistochemistry of explanted E9 chick nodose ganglion and nerve fibers. Double staining for neurofilament (red) and
GFR1 (green) are shown in the left and right columns. Merged images are shown in the last column. The first row (a–c) shows a low
magnification view of a nodose ganglion with overlapping neurofilament and GFR1 staining. Scale bar, 100 m. The middle row (d–f) shows
a higher magnification image of cells within the same ganglion double-labeled for neurofilament and GFR1. Scale bar, 50 m. The last row
(g–i) shows a close-up of fibers exiting the ganglion labeled with neurofilament but lacking GFR1 immunoreactivity. Scale bar, 50 m.
(E) Immunoblot of GFR1 in conditioned medium of fibroblasts (MG87), neuronal cells (RN33B), and explanted E9 chicken carotid body and
heart.
(F) Functional GFR1 in developing heart conditioned medium. Fibroblast cells expressing only c-Ret (MG87-Ret) were treated with GDNF
and purified GFR1-Fc or soluble GFR1 derived from heart conditioned medium as indicated. c-Ret phosphorylation was analyzed by
immunoprecipitation (IP) followed by immunoblotting (IB) with anti-phosphotyrosine antibodies.
GDNF or GDNF plus GFR1-Fc at E16 (Figure 2B). At tional functions for this signaling system in the matura-
tion or maintenance of connections.this time, a pronounced spontaneous outgrowth could
also be observed. Intriguingly, the lack of respon-
siveness at this later stage cannot be explained by a A Local Source of GFR1 Promotes Directional
Growth of Sensory and Sympathetic Axonsdownregulation of GDNF receptor expression (see Fig-
ure 1A), and most likely reflects developmental changes We next investigated whether GDNF and GFR1 could
affect the direction of axonal growth of sensory andin downstream signaling components. Together, these
results indicate that exogenous GFR1 is able to po- sympathetic neurons when presented from a localized
source. To this purpose, we cultured explants in colla-tentiate neurite outgrowth specifically at those times of
development when it is maximally expressed in periph- gen gels together with agarose beads soaked in different
proteins. In the first set of experiments, E9 nodose gan-eral targets, consistent with the possibility that target-
derived GFR1 functions as an outgrowth-promoting glion explants were cultured in medium containing
brain-derived neurotrophic factor (BDNF)—as a neuritefactor. The persistent expression of neuronal c-Ret and
GFR1 after the period of target innervation (i.e., E16), outgrowth inducer—together with beads soaked in BSA,
GDNF, GFR1-Fc, or GDNF plus GFR1-Fc. In thesetogether with the loss of neurite outgrowth responses
to GDNF and GFR1 at these later stages, suggest addi- conditions, only beads soaked in both GDNF and
Neuron
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Figure 2. Soluble GFR1 Potentiates Neurite Outgrowth in Developing Nodose and Sympathetic Ganglia
(A) Photomicrographs (left panels) of neurofilament immunofluorescence staining of explanted E9 chick nodose and sympathetic ganglia
growing in collagen gel matrices in the presence of GDNF (100 ng/ml) or GDNF plus soluble GFR1-Fc (300 ng/ml) as indicated. Scale bars,
200 m. Quantifications (right panels) of neurite length in explants of E9 chick nodose and sympathetic ganglia grown for 72 hr with the
indicated concentrations of GDNF and soluble GFR1 (in ng/ml). Results are presented as average  SD of two independent experiments
performed in triplicate.
(B) Quantifications of neurite outgrowth area (relative to total explant area, see Experimental Procedures) and length in explants of chick
nodose and sympathetic ganglia of different developmental ages grown for 72 hr with GDNF (100 ng/ml) and soluble GFR1 (300 ng/ml) as
indicated. Results are presented as average  SEM of three independent experiments each measured in quadruplicate. ***, p  0.0001; **,
p  0.01; *, p  0.05 (ANOVA). At least 15 neurites were evaluated in each explant.
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Figure 3. A Local Source of GFR1 Induces
Directional Growth of Sensory and Sympa-
thetic Axons
(A) Nodose ganglion explants (E9) were cul-
tured in collagen gels containing BDNF to-
gether with agarose beads soaked in BSA,
GDNF, or GDNF plus GFR1-Fc as indicated.
After 72 hr, the explants were fixed and
stained with anti-neurofilament antibodies.
Scale bars, 200 m. The histogram shows
the quantification of neurite outgrowth in the
quadrants proximal (solid bars, “toward”) and
distal (hatched bars, “away”) to the beads.
Results are presented as average SEM. For
each condition, a total of 25–30 explants were
evaluated in three independent experiments.
*, p  0.05 (ANOVA).
(B) Nodose and sympathetic ganglion ex-
plants (E9) were cultured in collagen gels con-
taining a uniform concentration of GDNF (100
ng/ml) together with agarose beads soaked
in IgG or in GFR1-Fc as indicated. Results
are presented as average  SEM. For each
condition, a total of 2530 explants were
evaluated in three independent experiments.
***, p  0.0001 (Student’s t test).
GFR1-Fc were capable of inducing a clear and robust ence of a uniform concentration of GDNF (Figure 3B).
This chemoattractive effect of GFR1-Fc could also bedirectional outgrowth of neurites toward the beads (Fig-
ure 3A). In the absence of GFR1-Fc, GDNF had only a observed in the presence of BDNF, for nodose ganglion
explants, or nerve growth factor (NGF), for sympatheticvery modest effect, while GFR1-Fc alone or BSA were
completely inactive. Interestingly, however, an attractive explants, two strong inducers of neurite outgrowth in
these neurons (data not shown). Together, these resultseffect of beads soaked in GDNF could be observed if
soluble GFR1 was added to the medium (Figure 3A). indicate that exogenous GFR1 can create positional
information for c-Ret-expressing axons even in the pres-The requirement of exogenous GFR1 for the effects of
GDNF on the directional growth of nodose ganglion fi- ence of a uniform concentration of GDNF and in the
presence of other outgrowth-promoting factors.bers prompted us to examine whether a localized source
of GFR1 could also influence the direction of neurite
outgrowth in the presence of a uniform concentration of Immobilized GFR1 Can Drive and Reorient
Axonal Growth along Sites of GFR1 ExpressionGDNF. Explants of E9 nodose and sympathetic ganglia
were cultured in medium containing a saturating dose GDNF and GFR1 mRNA and protein were also detected
in mesenchymal and glial cells isolated from developingof GDNF together with beads soaked in GFR1-Fc or
in control IgG. A strong directed outgrowth could be sensory nerves and expanded in vitro (data not shown),
indicating that they could provide local stimulation toobserved toward beads soaked in GFR1-Fc in the pres-
Neuron
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Figure 4. Immobilized GFR1 Can Drive and Reorient Axonal Growth along Sites of GFR1 Expression
(AD) Photomicrographs of nodose ganglion explants stained with anti-neurofilament antibodies cultured in collagen gels containing GDNF
(100 ng/ml) or GDNF plus BDNF (10 ng/ml) together with beads soaked in IgG (A and B) or GFR1-Fc (C and D). Scale bar, 200 m.
(E and E) High magnification images (from panel C) of nodose ganglion neurites growing on agarose beads soaked in GFR1-Fc. (E) and (E)
represent two different confocal planes of the same region. Scale bar, 200 m.
(F and G) Nodose ganglia explanted with a piece of nerve growing in collagen gels containing a uniform concentration of GDNF and BDNF,
together with beads soaked in IgG (F) or GFR1-Fc (G) placed at a right angle over the tip of the nerve. Scale bar, 400 m.
(H and I) Explants of nodose ganglia plus nerve growing in a uniform concentration of GDNF together with beads soaked in GFR1-Fc placed
at a right angle in the middle portion of the nerve. Arrowhead in (F) indicates neurites emanating from the ganglion toward the beads. Scale
bar, 150 m. A higher magnification is shown in (I). One of the beads (asterisk) appears encircled in neurites. Scale bar, 60 m.
growing sensory fibers during target innervation and finding behavior of pre-existing axons. To this purpose,
we cultured explants of E9 nodose ganglia together withregeneration. Since GFR1 is initially synthesized as a
membrane-anchored molecule, we investigated local- a piece of nerve in collagen gel matrices, and placed
rows of agarose beads soaked in GFR1-Fc at a rightized effects of GFR1 presented on rows of agarose
beads directly in contact with ganglion explants cultured angle over the tip of the nerve. A combination of GDNF
and BDNF was applied in the culture medium over ain a uniform concentration of GDNF, thereby mimicking
a feature of the molecular environment encountered by period of three days. Control beads soaked in IgG had
no effect on the direction of growth of axons emerginggrowing axons in developing nerves and targets. Neu-
rites induced in the presence of GDNF, or a combination from the explanted nerve (Figure 4F). In contrast, beads
soaked in GFR1-Fc produced a dramatic change inof GDNF and BDNF, ignored beads soaked in IgG and
extended in all directions from the explant (Figures 4A the pathfinding behavior of sensory axons, which turned
at a right angle to grow over the path delineated by theand 4B). In stark contrast, beads soaked in GFR1-Fc
promoted a robust growth of neurites that followed the GFR1-containing beads (15 of 15 explants examined)
(Figure 4G). Importantly, beads coated with GFR1-Fcpath demarcated by the beads (15 of 15 explants exam-
ined) (Figure 4C). Even the additional neuritic growth had no effect on the direction of axon growth if GDNF
was omitted from the medium (see Supplemental Figurestimulated by BDNF was oriented to converge and grow
over the beads containing GFR1-Fc (Figure 4D). At S2 on the Neuron website).
We also asked whether GFR1 could alter the normalhigher magnification, a dense web of neurites could be
observed ensheathing the beads soaked in GFR1-Fc trajectory of axons within a nerve. For this purpose, we
placed rows of beads soaked in GFR1-Fc at a right(Figures 4E and 4E). These results indicated that, in the
presence of GDNF, a spatially confined source of GFR1 angle in the middle portion of explanted nodose gan-
glion nerves. After three days in culture in the presencecan act as a local directional cue for growing sensory
axons, orienting and stabilizing them along sites of of GDNF, we observed extensive outgrowth of neurites
emanating from the nerve and extending over the beadsGFR1 expression.
The robust ability of exogenous GFR1 to promote containing GFR1 (Figure 4H); in some cases, axons
were seen completely encircling the beads (10 of 10and direct de novo axonal growth in the presence of
GDNF prompted us to examine its effects on the path- explants examined) (Figure 4I). Together, these localized
GFR1 and Cdk5 in Axon Growth and Guidance
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Figure 5. Increased and Sustained Activation of Cyclin-Dependent Kinase 5 (Cdk5) by GDNF in the Presence of Exogenous GFR1
(A) Cdk5 kinases assay in MN1 cells treated with GDNF (100 ng/ml) or GDNF plus GFR1 (300 ng/ml) for the indicated times. Immunoprecipitation
of Cdk5 was followed by in vitro kinase assay using histone H1 as substrate and autoradiography. Reprobing of the same blot with Cdk5
antibodies is shown below.
(B) Inhibition of Cdk5 activity in MN1 cells stimulated with GDNF and soluble GFR1 by the Cdk5 inhibitor Roscovitine (50 M). The same
concentration of Roscovitine had no effect on MAP kinase activity (not shown).
(C) Inhibition of Cdk5 activity in MN1 cells stimulated with GDNF and soluble GFR1 (6 hr) by the MEK inhibitor PD98059 and the PI3K inhibitor
Ly294002 (each at 50 M).
(D and E) Inhibition of Cdk5 activity in MN1 cells stimulated with GDNF and soluble GFR1 by 30 min pre-incubation with 2 g/ml actinomycin
D (D) or 25 M cycloheximide (E).
(F) Induction of kinase activity associated to the Cdk5 regulator p35 in MN1 cells after 6 hr stimulation with GDNF and soluble GFR1.
Reprobing with anti-p35 antibodies shows that treatment with GDNF and GFR1 had no major effect on p35 levels in these cells.
effects of exogenous GFR1 on the direction of growth tiation (York et al., 1998). However, the pathways linking
sustained activation of Erk kinases to neuronal differen-of sensory neurites document the ability of this protein
to influence axon guidance. tiation are only beginning to emerge. One such link may
be represented by the cyclin-dependent kinase 5 (Cdk5)
(Harada et al., 2001). Cdk5 is an atypical member of theIncreased and Sustained Activation of Cyclin-
serine/threonine cyclin-dependent kinase family that isDependent Kinase 5 (Cdk5) by GDNF
highly expressed in the nervous system (reviewed byin the Presence of Exogenous GFR1
Dhavan and Tsai, 2001). Although a role for Cdk5 in cellIn our previous work, we demonstrated that exogenous
cycle regulation has not yet been identified, this kinaseGFR1 can potentiate and prolong downstream signal-
has been implicated in neuronal cell migration and axoning in response to GDNF (Paratcha et al., 2001). In partic-
guidance (Dhavan and Tsai, 2001). Activation of Cdk5ular, stimulation with GDNF and soluble GFR1-Fc re-
requires its association with either one of two cyclin-sulted in a more sustained phosphorylation of Erk and
like proteins, p35 and p39, as well as phosphorylationAkt kinases compared to treatment with GDNF alone in
(Dhavan and Tsai, 2001).developing sensory and sympathetic neurons and in
We investigated the participation of Cdk5 in GDNFthe motor neuron cell line MN1 (Paratcha et al., 2001).
signaling, and its possible role in neurite outgrowth andSustained activation of signaling pathways, in particular
Erk kinases, has been associated with neuronal differen- axon guidance induced by exogenous GFR1. In the
Neuron
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Figure 6. Cdk5 Activity Is Required for Neuronal Differentiation of MN1 Cells Mediated by GDNF and Soluble GFR1
(A) MN1 cell differentiation mediated by GDNF (100 ng/ml) and soluble GFR1 (300 ng/ml) is inhibited by Roscovitine. Photomicrographs show
MN1 cells stained with Phalloidin, which reveals polymerized actin filaments. The histogram shows the quantification of the relative number
of cells bearing neurites longer than 1.5 cell diameters in different conditions. The results are averages  SD of a representative experiment
performed in triplicate. *, p  0.0001 versus GDNF  GFR1 alone (ANOVA).
(B) Inhibition of MN1 cell differentiation by expression of a dominant-negative Cdk5 mutant. GFP was transfected in MN1 cells in the presence
or absence of the Cdk5 (N144) dominant-negative construct. The histogram shows the quantification of the relative number of neurite-bearing
cells in each condition. The results are averages  SD of a representative experiment performed in triplicate. *, p  0.0001 versus GDNF 
GFR1 alone (ANOVA).
first set of experiments, we used the motor neuron cell lated kinase activity in p35 immunoprecipitates without
inducing appreciable changes in p35 levels (Figure 5F).line MN1 stimulated with either GDNF alone or a combi-
nation of GDNF plus GFR1-Fc. Using an in vitro kinase Using real time PCR, we could independently verify that
treatment with GDNF and GFR1 had no effects on theassay with Histone 1 (H1) as exogenous substrate, a
modest stimulation of Cdk5 kinase activity could be total levels of p35 or p39 mRNAs in MN1 cells (data
not shown). Together, these results indicate that thedetected after 4 hr treatment with GDNF (Figure 5A).
Addition of GFR1-Fc together with GDNF resulted in combination of GDNF and exogenous GFR1 can pro-
mote sustained activation of Cdk5 in MN1 cells via thea more pronounced and sustained activation of Cdk5
which lasted for at least 8 hr (Figure 5A). Kinase activity MEK/Erk and PI3K pathways, and suggest the participa-
tion of the Cdk5 activator p35. However, although Cdk5in Cdk5 immunoprecipitates could be blocked by the
specific Cdk5 inhibitor Roscovitine (Figure 5B). Impor- activation by GDNF and GFR1 requires de novo tran-
scription and translation, the mechanism of kinase acti-tantly, Roscovitine did not affect Erk phosphorylation
under the same conditions (data not shown). Activation vation does not appear to involve upregulation of p35
or p39.of Cdk5 could be blocked by the MEK inhibitor PD98059
and by the PI3K inhibitor Ly2940002 (Figure 5C), indicat-
ing the participation of both these pathways in Cdk5 Cdk5 Activity Is Required for Neuronal
Differentiation of MN1 Cells Mediatedactivation by GDNF and GFR1. In contrast, the specific
Src-family kinase inhibitor PP2 had no effect on the by GDNF and Soluble GFR1
In the presence of GDNF and soluble GFR1, MN1 cellsregulation of Cdk5 activity by GDNF (data not shown).
In agreement with the slow kinetics of stimulation of adopt a flattened morphology (i.e., cell spreading) and
develop long neuritic processes (Figure 6A and ParatchaCdk5 activity in response to GDNF and GFR1, both
actinomycin D (Figure 5D) and cycloheximide (Figure et al., 2001). This morphological differentiation of MN1
cells could be blocked by Roscovitine (Figure 6A), sug-5E) inhibited Cdk5 activation by these factors, indicating
the requirement of transcription and translation for this gesting the requirement of Cdk5 activity. The effect of
the inhibitor was verified using a dominant-negativesignaling event. Finally, GDNF and GFR1 also stimu-
GFR1 and Cdk5 in Axon Growth and Guidance
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form of Cdk5 (Nikolic et al., 1996). MN1 cells were trans-
fected with a GFP expression plasmid in the absence
or presence of the Cdk5 dominant-negative construct
and stimulated with GDNF and soluble GFR1. Blockade
of Cdk5 activity resulted in a complete inhibition of the
effects of GDNF and GFR1 on MN1 cell differentiation
and neurite outgrowth as assessed by examination of
the morphology of GFP-positive cells (Figure 6B). Similar
results were obtained in PC12 cells co-transfected with
c-Ret and dominant-negative Cdk5 treated with GDNF
and GFR1 (data not shown). These results demonstrate
the requirement of Cdk5 for the effects of GDNF and
GFR1 on neuronal differentiation and neurite out-
growth.
Requirement of Cdk5 Activity for GFR1-Mediated
Neurite Outgrowth and Axon Guidance
in Sympathetic Neurons
In agreement with the results obtained in MN1 cells,
GDNF and soluble GFR1 also induced increased Cdk5
kinase activity in dissociated cultures of E9 chicken
sympathetic neurons with a delayed kinetics (Figure 7A).
This increase in Cdk5 activation could also be blocked
by Roscovitine (Figure 7A). To determine the importance
of exogenous GFR1 in the activation of c-Ret receptors
in distal axons, we utilized compartmentalized cultures
of sympathetic neurons. Stimulation of distal axons with
GDNF and GFR1 induced activation of Cdk5, while
treatment with GDNF alone had no effect (Figure 7B),
indicating that exogenous GFR1 is required for activa-
tion of Cdk5 by a source of GDNF locally applied to
axon terminals.
We then examined the requirement of Cdk5 activation
for the neurite outgrowth induced by GDNF and soluble
GFR1-Fc in sympathetic ganglion explants. In the pres-
ence of Roscovitine, neurite outgrowth stimulated by
GDNF and GFR1 was severely impaired (Figure 8A).
Figure 7. Requirement of Exogenous GFR1 in Distal Axons forInterestingly, low doses of Roscovitine (10 M) affected
GDNF-Mediated Activation of Cdk5 in Sympathetic Neuronsmainly the potentiated response obtained in the pres-
(A) Cdk5 kinase activity in dissociated cultures of E9 chick sympa-ence of soluble GFR1 (primarily its effects on the area
thetic neurons. Cultures were treated with GDNF and soluble GFR1of neurite outgrowth), while sparing outgrowth responses
for the indicated times in the presence or absence of Roscovitineto treatment with GDNF alone (Figure 8A). At higher
(50 M). Reprobing control was done with antibodies against chick
doses (25 M), Roscovitine had pronounced inhibitory -tubulin.
effects on the area of neurite outgrowth and the neurite (B) Cdk5 kinase activity in dissociated cultures of E21 rat superior
cervical ganglion neurons grown in compartmentalized chambers.length in response to both GDNF and GDNF plus soluble
The distal axon compartment was stimulated for 6 hr with GDNF inGFR1 (Figure 8A). Similar effects were also observed
the presence or absence of soluble GFR1. Total cell lysates werein explants of E9 nodose ganglia (data not shown). At
prepared from the pooled compartments and subjected to immuno-neither dose did Roscovitine affect neuronal survival,
precipitation (IP) with anti-Cdk5 antibodies. Immunoprecipitates
as demonstrated in dissociated neuronal cultures grown were used for kinase assay as above. Reprobing control was done
in the presence of GDNF and GFR1. These cultures with antibodies against -tubulin. The experiment was repeated two
times with similar results.also revealed the inhibitory effects of Roscovitine on
neurite outgrowth (Figure 8B). The participation of Cdk5
signaling in neurite outgrowth promoted by GDNF and
GFR1 could also be demonstrated with the dominant- dium containing GDNF and NGF. Neurites induced in
the presence of GDNF and NGF were directed towardnegative Cdk5 construct N144. In this experiment, ex-
pression of the dominant negative caused a marked the beads containing GFR1 (Figure 7D). In the presence
of low concentrations of Roscovitine (12.5 M), how-reduction in neurite outgrowth responses to GDNF 
GFR1 in sympathetic neurons (Figure 8C). ever, directed outgrowth of sympathetic neurites toward
GFR1-containing beads was inhibited (Figure 7D). Im-Lastly, we investigated the role of Cdk5 in the ability
of a localized source of GFR1 to promote directional portantly, under the conditions used in this experiment
(i.e., low concentration of Roscovitine and NGF in thegrowth of sympathetic axons. To this purpose, we cul-
tured explants of E9 sympathetic ganglia in collagen medium), the drug treatment had no effect on the overall
neurite outgrowth response of the explants, i.e., axonsgels together with beads soaked in GFR1-Fc in a me-
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Figure 8. Requirement of Cdk5 Activity for GFR1-Mediated Neurite Outgrowth and Axon Guidance in Sympathetic Neuron
(A) Roscovitine blocks neurite outgrowth stimulated by GDNF and soluble GFR1 in explanted sympathetic ganglia. Both neurite outgrowth
area and length are shown. The results are averages  SEM of a representative experiment.
(B) Dissociated sympathetic neurons grown in culture in the presence of GDNF plus GFR1 in the presence or absence of Roscovitine (25
M). After 48 hr in culture, the cells were fixed and stained with anti-neurofilament antibodies. Arrowheads indicate neuronal cell bodies.
(C) Inhibition of neurite outgrowth in sympathetic neurons by expression of the dominant-negative Cdk5 mutant N144. GFP was transfected
in E9 chick sympathetic neurons in the presence (N144) or absence (control) of the Cdk5 dominant-negative construct. Cultures were then
stimulated with GDNF and soluble GFR1. The histogram to the left shows the quantification of the neurite length in the two conditions. The
GFR1 and Cdk5 in Axon Growth and Guidance
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extended normally but were not attracted by the beads of exogenous GFR1 on neurite outgrowth. On the one
hand, stimulation of c-Ret in trans by exogenous GFRsoaked in GFR1 (Figure 7D). Together, these results
demonstrate that activation of Cdk5 is not only required molecules could be eliciting qualitatively or quantita-
tively distinct signaling responses compared to activa-for neurite outgrowth induced by GDNF and GFR1, but
also for the ability of exogenous GFR1 to promote axon tion in cis. Previous work from ours and other labora-
tories has demonstrated that activation of c-Ret in transguidance when presented from a localized source.
results in a different kinetics of activation of this recep-
tor, consisting of a first phase of activation outside lipidDiscussion
rafts followed by a delayed but sustained recruitment
to this membrane compartment (Paratcha et al., 2001;Examination of the expression patterns of GDNF family
ligands and their receptors have pointed to additional Tansey et al., 2000). This results in a prolonged activa-
tion of c-Ret and downstream pathways, including thefunctions for this group of molecules in the developing
and adult nervous system (Fundin et al., 1999; Naveilhan serine-threonine kinases Erk and Akt (Paratcha et al.,
2001). Although it is not known at present whether acti-et al., 1997; Trupp et al., 1997; Yu et al., 1998). The wide
expression of GFR molecules in the absence of c-Ret, vation of c-Ret in cis and in trans differ in some of their
downstream targets, these results suggest that theretogether with their ability to activate this receptor in
trans when presented in soluble form in the presence could be differences in signaling between the two activa-
tion regimes. On the other hand, the effects of exoge-of GDNF ligands, have suggested non-cell-autonomous
roles for GFR proteins during nervous system develop- nous GFR1 on axonal growth and guidance could also
be explained by our observation of a relative deficit ofment and regeneration. In many cases, these “ectopic”
sites of GFR expression are associated with targets of GFR1 molecules in axons compared to cell bodies of
developing sensory and sympathetic neurons. In con-c-Ret-expressing neurons, as in the trigeminal, hippo-
camposeptal, thalamocortical, and retinotectal path- trast, c-Ret immunoreactivity is observed in both neu-
rites and cell bodies, suggesting that the relatively lowways, or in close juxtaposition to c-Ret-expressing cells
(Fundin et al., 1999; Trupp et al., 1997; Yu et al., 1998). abundance of endogenous GFR1 in axons and growth
cones may be limiting for c-Ret activation by GDNF inThe expression of GFR1 by accessory cells in develop-
ing peripheral nerves and their targets suggests a physi- these compartments. In agreement with this, we find
that although GDNF is on its own able to stimulate Cdk5ological role for this molecule in the development of
axonal projections, target invasion and the refinement of when supplied to whole-cell cultures of sympathetic
neurons, it requires GFR1 when administered specifi-synaptic contacts with targets. In this work, we present
evidence supporting a role for target-derived GFR1 in cally to the distal axons of these cells. This localized
action could explain the remarkable effects of exoge-the growth and guidance of developing sensory and
sympathetic axons. nous GFR1 on axon guidance and branching, particu-
larly when presented locally in close proximity to axons
and axon terminals. Intriguingly, expression of GFR1GFR Proteins as Molecular Cues for Axonal
Growth and Guidance is developmentally downregulated in heart and carotid
body, two targets of nodose ganglion sensory neurons,The cellular and molecular mechanisms that participate
in axonal growth and guidance during development and in temporal coincidence with the completion of target
innervation and the loss of neuronal responsiveness toregeneration are still not fully understood. Our results
indicate a novel, non-cell-autonomous role for GFR exogenous GFR1, suggesting a physiological signifi-
cance for the differential subcellular localization ofproteins in these processes. Although GFR1 is co-
expressed with c-Ret in sensory and sympathetic neu- GDNF receptors in developing neurons. In direct support
of this notion, a recent study of the distribution of GDNFrons, we find that soluble GFR1 is able to potentiate
neurite outgrowth induced by GDNF. Moreover, our re- receptors in cutaneous targets of trigeminal ganglion
neurons identified a close juxtaposition between sen-sults demonstrate striking localized effects of exoge-
nous GFR1 on the direction of growth of new and pre- sory nerve endings expressing c-Ret, but lacking GFR1,
and terminal Schwann cells expressing GFR1, sug-existing axons which were not observed using GDNF
alone. This is in agreement with the inability of beads gesting local interactions that may be essential for the
formation of sensory terminals (Fundin et al., 1999).soaked in just GDNF to promote directional outgrowth
in explanted mouse superior cervical ganglia and lumbar Gradients of long-range guidance cues constitute an
important mechanism for the specification of neuronaldorsal root ganglia (Young et al., 2001). We can think of
at least two complementary explanations for the effects connections. Several classes of neurotrophic factors,
results are averages  SEM of a representative experiment performed in triplicate. *, p  0.001 (Student’s t test). The experiment was repeated
three times with the same results. The histogram to the right shows the frequency of neurons found carrying neurites in different length
categories after transfection with Cdk5 N144 (solid bars) or GFP alone (control, stippled bars). Note the marked shift to the left of the distribution
of neurons that received the dominant-negative construct.
(D) Roscovitine inhibits the chemotropic activity of exogenous GFR1 on sympathetic axons. Sympathetic ganglion explants were cultured
for 48 hr in collagen gels containing GDNF (100 ng/ml) and NGF (2 ng/ml) together with agarose beads soaked in GFR1-Fc in the presence
or absence of Roscovitine (12.5 M). The first histogram shows the quantification of relative neurite outgrowth area toward (solid bars) and
away (hatched bars) from GFR1 beads. For each condition, a total of 15 explants were evaluated. Results are presented as mean  SD of
two independent experiments. *, p  0.01 (Student’s t test). The second histogram shows the quantifications of total neurite outgrowth area
(relative to total explant area) from the same experiments.
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including members of the neurotrophin (Tucker et al., of Drosophila Cdk5 result in errors in axonal pathfinding
and target recognition by abdominal motor neurons2001) and GDNF ligand families, are known to contribute
to axonal growth during development. GDNF and the (Connell-Crowley et al., 2000). p35, also known as neu-
ronal Cdk5 activator (NCK5a), has been identified asrelated factor NTN have recently been proposed as tar-
get-derived signals for developing cilliary ganglion neu- an indispensable Cdk5 activator in neurons (Tsai et al.,
1994). p35 and the related protein p39, also known asrons (Hashino et al., 2001); and ART, another member
of the GDNF ligand family, is an important regulator of NCK5a isoform (NCK5ai), are small cyclin-like proteins
that are capable of activating Cdk5 by direct associa-the growth and guidance of sympathetic axons from the
developing superior cervical ganglion (Enomoto et al., tion. A recent study has demonstrated that sustained
Erk activation in response to NGF was sufficient for2001). Until now, however, target-derived neurotrophic
receptors were not known to have non-cell-autonomous induction of p35 expression leading to Cdk5 activation
and neuronal differentiation of PC12 cells (Harada et al.,effects on axonal growth and guidance. A feature shared
by GPI-anchored proteins is that they can be found in 2001). In addition, BDNF has also been shown to induce
Cdk5 kinase activity in primary cerebellar cells in cultureeither membrane bound or soluble forms. Secretion of
biological, active GFR1 by known targets of c-Ret ex- (Harada et al., 2001). In our previous work, we demon-
strated that activation of c-Ret in trans by GDNF andpressing neurons may form diffusible gradients of this
protein that can promote long-range effects on the soluble GFR1 induces strong and sustained activation
of MAP kinases Erk1 and 2 as well as Akt (Paratcha etgrowth and guidance of developing sensory and sympa-
thetic axons. On the other hand, our previous results al., 2001). Our present results suggest that the prolonged
activation of these pathways leads to sustained Cdk5have demonstrated that GPI-anchored GFR1 mole-
cules on stand-by cells can also capture and present activity, which is in turn required for the neurite out-
growth and guidance activities of exogenous GFR1.GDNF in trans to c-Ret receptors on adjacent cells (Pa-
ratcha et al., 2001), supporting the ability of exogenous Although our data showed that treatment with GDNF
and GFR1 stimulates Cdk5 activity in complex withGFR1 to produce localized effects. Our present results
using microspheres coated with GFR1 indicate that p35, and indicated the requirement of gene transcription
and protein translation, we have not detected anyactivation of c-Ret in trans by cell-cell contact may play
a role in stabilizing axonal trajectories along sites of changes in the levels of expression of either p35 or p39
in response to GDNF and GFR1. This suggests theGFR1 expression. Thus, GFR1 has the capacity to
elicit both long-range and localized guidance effects existence of alternative mechanisms of Cdk5 activation
in these cells, perhaps mediated by Cdk5 phosphoryla-by creating positional information for c-Ret-expressing
axons even in the presence of a uniform concentration tion. A role for Cdk5 in neurite outgrowth mediated by
exogenous GFR1 was demonstrated using the specificof GDNF. GFR1 can thus rearrange GDNF into spatial
patterns that may be different from the patterns of GDNF inhibitor Roscovitine and the N144 dominant-negative
Cdk5 mutant. Intriguingly, dose-response experimentsgene expression.
Clearly, a number of target-derived molecules, in addi- indicated that lower doses of the inhibitor preferentially
blocked the effects of exogenous GFR1 on axonaltion to GDNF and GFR1, are likely to contribute to
axonal growth and guidance of peripheral projections growth. Moreover, low concentrations of Roscovitine
effectively blocked the attractive effect of a localizedin vivo, a fact that may complicate the analysis of spe-
cific loss-of-function animal models. In addition to the source of GFR1 on axons growing in a combination of
GDNF and NGF without affecting overall neuritic growth.neurotrophins and other neurotrophic factors, members
of other families of guidance molecules, such as sema- This experimental setup allowed us to dissociate the
effects of Cdk5 on neurite outgrowth and axon guidance.phorins, netrins, and slits, are known to contribute to
these processes. Functional redundancy is also likely The fact that one but not the other could be inhibited
with low doses of Roscovitine underlies the specificto occur within the GDNF signaling system itself, as
indicated by our observation that GFR2, a GFR1 ho- involvement of Cdk5 in the biological activities of exoge-
nous GFR1, and suggests that axon guidance medi-molog that can also act as a receptor for GDNF (Sanicola
et al., 1997; Trupp et al., 1998), is also expressed by ated by this receptor requires a higher threshold of Cdk5
activity.target cells of sensory neurons and has effects on axonal
growth and guidance that are comparable to those re- In conclusion, our observations suggest a model in
which GDNF, together with soluble and membraneported here for GFR1 (F.L., unpublished observations).
Thus, complex, developmentally regulated signaling bound GFR1 produced by target and accessory nerve
cells, interact with c-Ret at axon terminals and initiatenetworks are likely to contribute to the development and
maturation of peripheral projections. local signaling cascades that propagate from distal ax-
ons to the cell nucleus where they activate the expres-
sion of factors critical for Cdk5 activation, ultimatelyRole of Cdk5 in Axon Guidance
leading to enhanced axonal growth.by Exogenous GFR1
Cdk5 is the only member of the Cdk family which is not
Experimental Proceduresknown to have a role in cell cycle regulation. Most stud-
ies on this kinase indicate pleiotropic cellular functions
Cell Lines and Recombinant Proteinsfor Cdk5 in cell migration, membrane transport, synaptic
RN33 is a conditionally immortalized neuronal precursor cell line
function, and axon guidance (Dhavan and Tsai, 2001). isolated from embryonic raphe nucleus (Trupp et al., 1999; White
The role of Cdk5 in axon guidance appears to be highly et al., 1994). MG87-Ret lines were derived from MG87 fibroblasts
by stable transfection with c-Ret. MN1 is an immortalized motorneu-conserved during evolution, as alterations in the activity
GFR1 and Cdk5 in Axon Growth and Guidance
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ron cell line that is responsive to GDNF (Trupp et al., 1999). GDNF For neurite outgrowth assay, chick nodose and paravertebral sym-
pathetic ganglia were dissected at different times of embryonic (E)and GFR1-Fc were purchased from R&D. NGF was purchased from
development (E6, E9, E13, E16). The explants were cultured in ratPromega, and BDNF was kindly provided by Regeneron Pharmaceu-
tail collagen gels as previously described (Ebendal, 1989) in theticals.
presence of the specified neurotrophic factors. For directed neurite
outgrowth assays, 10 l of agarose beads (Sigma Chemical, Co)Cell Transfection, Plasmids, and Pharmacological
were washed in PBS and incubated with 2 g of BSA, IgG, GDNF,Treatments
or GFR1-Fc over night at 4	C in a total volume of 50 l. In someTransient transfection of MN-1 cells were performed in 24 well plates
cases, 25 l of beads coated with GFR1-Fc were incubated with(1 g total DNA/well) in 0.5 ml of DMEM with 1% serum using
GDNF (2 g) for 4 hr at 4	C, washed again, and inserted in collagenthe Fugene-6 reagent (Roche). Transfection of primary sympathetic
gel matrices. After 3 days in culture, the explants were fixed withneurons was performed by the same method in DMEM:F12 serum-
4% paraformaldehyde, permeabilized with 0.3% Triton X-100, andfree medium. Plasmid cDNA encoding Cdk5DN (N144) was kindly
stained as indicated below.provided by Dr Li-Hue Tsai (Department of Biological Sciences,
University of South Carolina). Plasmid cDNA encoding GFP was
Immunofluorescence and Microscopyfrom Clontech. The Cdk5 inhibitor, Roscovitine, was purchased from
GFR1 staining was done on non-permeabilized, paraformalde-Calbiochem and used at the specified concentrations. The protein
hyde-fixed dissociated neuronal cultures (or ganglion whole mounts)translation inhibitor cycloheximide (Sigma) was used at 25 g/ml,
by overnight incubation with an affinity-purified anti-GFR1 anti-and the transcription inhibitor actinomycin D (Sigma) at 2 g/ml.
serum, kindly provided by M. Sanicola, used at 1:400 dilution. Neu-MEK and PI3K inhibitors PD98059 and Ly294002 (Calbiochem) were
rofilament staining was done after permeabilization with 0.3% Tritonused at 50 M. Src inhibitor PP2 (Alexis) was used at 1 M.
X-100 at room temperature and incubated at 4	C overnight with
an anti-neurofilament antibody (Zymed) at 1:1500 dilution. TRITC-
Immunoprecipitation, Western Blotting, and Kinase Assay conjugated secondary antibodies (Jackson Lab) were used at 1:200
For total cell lysates, cells were lysed at 4	C in buffer containing 0.5% dilutions. Alexa-conjugated Phalloidin was from Molecular Probes.
Triton X-100, 1% -octylglucoside plus protease and phosphatase After immunostaining, confocal microscopy was performed in a
inhibitors. Protein lysates were clarified and analyzed by immuno- Zeiss LSM 510 confocal microscope with 5
 and 25
 objective
precipitation and Western blotting as previously described (Parat- lenses using laser excitation wavelengths of 543 nm and 488 nm.
cha et al., 2001). All blots were scanned in a Storm 840 fluorimager Neurite outgrowth from peripheral ganglion explants was quanti-
(Molecular Dynamics), and quantifications were done with Im- fied using the Axiovision software (Zeiss) version 2.01. The areas
ageQuant software (Molecular Dynamics). Numbers below the lanes covered by the entire explant (ganglion plus neurites) and the neu-
indicate fold of induction relative to control normalized to total levels rites alone (from the outer perimeter of the ganglion) were measured
of target protein. and used to calculate the percentage of neurite outgrowth as the
The antibodies were obtained from various sources as follows: area occupied by neurites, divided by the total area of the explant,
anti GFR1 was kindly provided by Michael Sanicola, Biogen; anti- multiplied by 100. This value automatically normalizes neurite out-
phosphotyrosine, anti-Ret, anti-p35, and anti-Cdk5 were from Santa growth measurements among explanted ganglia of different sizes
Cruz Biotechnology (Santa Cruz, California). For kinase assay, en- and reflects both the length and the number of neurites (Wang
dogenous Cdk5 and p35 were immunoprecipitated from cell lysates et al., 1996). In addition, neurite length was directly quantified by
by incubation with 1.5 g anti-Cdk5 or anti-p35 antibodies for 16 measuring the distance between the tip of the neurite and the outer
hr at 4	C and then 2 hr with protein G Sepharose beads (Pharmacia). border of the ganglion. For each explant, the lengths of the 15
The beads were precipitated, washed, and then mixed with 10 g longest neurites were measured and averaged. In each experiment,
of histone H1 in kinase reaction buffer (20 mM HEPES [pH 7.4], 2 measurements were taken in three to four different explants as
indicated in the figure legends.mM EGTA, 1 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 1 mM sodium
To quantify directional axon growth, the field was divided intovanadate, 20 mM sodium fluoride, and protease inhibitors) with
four orthogonal quadrants and the areas covered by neurofilament-100 M (32P)ATP (2 Ci). The reaction was performed at room
stained neurites (i.e., excluding the ganglion) were measured intemperature during 20 min and stopped by addition of sample buffer.
the distal (away) and proximal (toward) quadrants with respect to theAfter SDS-PAGE, radioactivity was analyzed in a Storm 840 phos-
position of the agarose beads (see also Alcantara et al., 2000). Thephorimager using ImageQuant software (Molecular Dynamics).
results are presented as percentage of neurite outgrowth toward or
away from the beads relative to the sum of the outgrowth in bothCompartmentalized Cultures
quadrants. Statistical analyses were performed by ANOVA and Stu-Compartmentalized cultures were performed as described by Cam-
dent t test using the program Statview.penot (1992). Briefly, 35 mm culture dishes were coated with rat
tail collagen, and parallel tracks in the substrate were made by
RT-PCRscratching the culture dish surface with a pin-rake (Tyler Research
The expression of c-Ret, GFR1, GDNF, and L27 was analyzed byInstruments, Canada). Subsequently, a two chambered Teflon di-
RT-PCR. Total RNA was isolated from nodose and sympatheticvider (Tyler Research Instruments) was seated on top of the tracks
ganglia, carotid body, and the superior area of the heart (close to theas described previously (Campenot, 1992). Dissociated E21 rat su-
point of entry of the great vessels) using SNAP columns (Invitrogen)
perior cervical ganglion neurons were plated in one compartment
according to the manufacturer’s instructions. Single-stranded cDNA
of a two-compartment chamber and maintained for 2 days in
was synthesized using Multiscribe reverse transcriptase and ran-
DMEM:F12 supplemented with 2 mM glutamine, 1 mg/ml BSA, dom hexamers (Perkin Elmer). The cDNA was amplified using the
10 M cytosine arabinoside (Sigma), and 100 ng/ml of NGF. After following primer sets: c-Ret: forward, 5 ATC CAG CTA TTT GCC
2 days, the medium was replaced for DMEM:F12 containing 20 ng/ml CCC AG 3; reverse, 5 CCA AGG TTT CCA GTG CCT TTC 3. L27:
of NGF in the cell body compartment and 100 ng/ml of NGF in forward, 5 GAT GCC CAC CCG GTA TTC T 3; reverse, 5AGC AGG
the side (i.e., distal-axon) compartment. The medium was changed GTC CCT GAA CAC AT 3. GFR1: forward, 5 AGT GTC ATA AGG
every 3 days, and after 10 days the cells were starved by incubation CCC TCC GG 3; reverse, 5 CAG GAG CAG AAG AGC ATC CC 3.
with anti-NGF blocking antibodies and then treated with GDNF or Real-time PCR was performed using a LightCycler rapid thermal
GDNF  GFR1 in the side compartment. Following 6 hr of treat- cycler system (PE) according to the manufacturer’s instructions.
ment, the cells were lysed and assayed for kinase activity as above. Reactions were performed in 25 l volume. Nucleotides, Taq DNA
polymerase, and buffer were included in the LightCycler–DNA Mas-
Neuronal Differentiation and Neurite Outgrowth Assay ter SYBR Green I mix (PE).
For MN1 cell differentiation assays, the number of cells with neurites
longer than 1.5 cell diameter were counted in random fields of three Acknowledgments
different wells in each experiment. GDNF was used at a saturating
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